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ABSTRACT
Dunn, Eric Joseph. M.S., Department of Neuroscience, Cell Biology, and Physiology,
Wright State University, 2015. Effect of Somatostatin on Voltage-Gated Calcium
Influx in Isolated Neonatal Rat Carotid Body Type I Cells.
Somatostatin (SST) is a neuropeptide hormone that regulates the release of
secondary hormones. Evidence suggests SST plays a neuromodulatory role due to
its distribution throughout the central nervous system. Interestingly, SST has been
suggested to affect the carotid body, the small peripheral chemoreceptors that
regulate breathing. It has been shown that the peripheral chemoreflex sensitivity to
CO2 and hypoxia is reduced by SST in humans (Pedersen et al., 1999; Pandit et al.,
2014). SST has also been found to inhibit whole cell Ca2+ currents recorded from
adult rat carotid body type I cells (e Silva & Lewis, 1995), but the mechanism by
which this occurs is unknown. This study aimed to identify the types of SST
receptors (SSTR) on type I cells and confirm the mechanism by which their
activation inhibits Ca2+ influx.
Specific antibodies were used to identify SSTR1-5 on type I cells, and results
showed that SSTR1-5 were present on the membrane and cytoplasmically in type I
cells. To record intracellular Ca2+ entry, type I cells were loaded with FURA-2 (5
μM) and depolarized in response to stimuli, including 80 mM K+ and hypoxia. Type I
cells applied with 2, 10, and 20 minute applications of 1 μM SST had no significant
inhibition on voltage-gated Ca2+ entry compared to controls. Also, a 2 minute
application of 1 μM SST did not significantly inhibit Ca2+ influx in adult rat type I
cells when compared to controls. These results indicate that 1 μM SST does not
significantly inhibit K+- nor hypoxic-evoked Ca2+ influx in isolated type I cells from
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carotid bodies. Thus the mechanism by which SST inhibits the acute ventilatory
response to hypoxia and hypercapnia is not likely via inhibition of voltage-gated
Ca2+ influx nor via inhibition of the chemosensory response of type I cells.
This work appeared in abstract form at the Ohio Physiological Society meeting 2014
and the Midwest Graduate Research Symposium 2015.
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INTRODUCTION
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Anatomy
The carotid bodies are peripheral chemoreceptors in mammals. They are
small organs located bilaterally in the neck, at the rostral end of the left and right
common carotid artery bifurcation (Figure 1) (Kumar & Prabhakar, 2012).
However, the exact location of the carotid body within the common carotid artery
varies among species (Gonzalez et al., 1994).
The carotid body is highly vascularized organ. It contains a dense network of
small blood vessels covering a large area of the organ (Gonzalez et al., 1994). Some
studies have suggested that the vascularization of carotid body exceeds that of the
brain by a factor of five to six (McDonald, 1981; Pallot, 1987). Blood is supplied to
the carotid body via small arteries branching from the common carotid artery
(Gonzalez et al., 1994). Venous drainage originates from one or a few small veins on
the surface of the organ, and ends in the internal jugular vein (Gonzalez et al., 1994).
As blood crosses the carotid body, it branches and continues to the superior
cervical cava (SCG). The carotid body is innervated by the SCG with the
ganglioglomerular nerves (Gonzalez et al., 1994). The carotid body is also
innervated by a branch of the glossopharyngeal nerve (GPN) called the carotid sinus
nerve (CSN), which connects the carotid body to the brain stem and regulates
respiratory control (Gonzalez et al., 1994). The CSN fibers are considered sensory
fibers rather than motor fiber, since the soma of the CSN is located in the petrosal
sensory ganglion and not in the brainstem (De Castro, 1928). De Castro (1928)
concluded that the carotid body was a sensory organ rather than a gland, when he
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found that the innervation of the carotid body parenchyma was unchanged when
the SCG was removed.
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Figure 1
Illustration showing the anatomical position of carotid body. The common carotid
artery (CC) splits into the internal (IC) and external (EC) branches. The carotid
body is located at the common carotid artery bifurcation.
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Physiological Function
The carotid bodies are the body’s main peripheral chemoreceptors that
modulate breathing. These organs are viewed as the primary peripheral sensor for
oxygen, and maintain and restore blood gas homeostasis by quickly responding to
hypoxia, hypercapnia, or acidosis (Peers et al., 2010). They have become
increasingly considered as polymodal organs, as they are sensitive to other stimuli,
including temperature changes and physiological osmolarity fluctuations (Peers et
al., 2010).
There are two distinct cell types that make up the carotid body- type I cells
and type II cells (Figure 2). In a carotid body, there are about 4 type I cells for every
type II cell (McDonald, 1981; Nurse & Piskuric, 2013). Type I cells are small
spherical cells (8-15 μm) that are arranged in clusters called glomoids (Nurse &
Piskuric, 2013), separated by connective tissue. These cells contain
neurotransmitters and synaptic vesicles, and are capable of forming electrical and
chemical synapses with other type I cells as well as other neuronal fibers, including
the CSN. Type I cells have a round nucleus and granular cytoplasm, though the
granular appearance is absent in type II cells (Gonzalez et al., 1994). Importantly,
type I cells depolarize in response to hypoxia, and transduce a chemical signal into
an action potential. These chemoreceptor cells play a transducer role that underlies
their presynaptic and neurosecretory function (Kumar & Prabhakar, 2012). In
contrast to type I cells, type II cells are not excitable and do not synapse with the
CSN. Type II cells are elongated, glia-like cells about 10 μm in diameter (Nurse &

6

Piskuric, 2013). They lack synaptic vesicles and are thought to play a supporting
role in the carotid body (Nurse & Piskuric, 2013).
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Figure 2
Picture illustrating the arrangement of cells in the carotid body. Elongated type II
cells encase type I cells. Type I cells, clustered in glomoids, contain
neurotransmitter and synapse with afferent chemosensory fibers such as the
carotid sinus nerve. The cells of the carotid body receive a rich supply of arterial
blood, shown by the capillary.
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Though isolated type I cells in culture have been shown to respond to
hypoxia, other transplant and regeneration studies have been performed to confirm
that the type I cell is the main transducing component of the carotid body, not only
in isolation (Kumar & Prabhakar, 2012). One study cryodestroyed type I cells and
found the chemosensory function of the carotid body to be lost (Verna et al., 1975),
suggesting that type I cells are the primary transducers of the carotid body (Kumar
& Prabhakar, 2012).

Neurotransmitter Release from Carotid Body Type I Cells
It has been clearly demonstrated that neurotransmitters are released from
type I cells under hypoxic conditions (Peers et al., 2010). When hypoxia induces
neurotransmitter release, the neurotransmitter excites afferent chemosensory
fibers and modulates respiratory reflexes (Peers et al., 2010). However, the
multitude of autocrine and paracrine effects of neurotransmitters on the carotid
body remain poorly described at this time (Gonzalez et al., 1994; Nurse, 2010; Wyatt
& Peers, 1993). Nonetheless, this secretory activity is viewed as a critical
component of the type I cell’s response to hypoxia (Peers et al., 2010).
The chemosensory mechanism of the type I cell that a majority of researchers
agree upon is the membrane hypothesis for oxygen sensing (Figure 3). Briefly,
hypoxia inhibits specific K+ channels (including BKCa channels), causing the type I
cell to depolarize (Peers et al., 2010). The increase in membrane potential opens
voltage-gated Ca2+ channels, and the Ca2+ influx initiates neurotransmitter release
(Peers et al., 2010). Previous work has shown that dihydropyridine-sensitive L-type
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Ca2+ channels account for part of this voltage-gated Ca2+ entry, but other voltagegated Ca2+ channels may also play a role since dihydropyridine receptor antagonists
do not completely block Ca2+ entry in response to high extracellular potassium
(Buckler & Vaughan-Jones, 1994).
However, there are some steps in the membrane hypothesis for oxygen
sensing that remain up for debate. For an example, an important, but unexplained
event in this hypothesis is how exactly hypoxia causes inhibition of K+ channels
(Prabhakar & Peers, 2014). It is also unknown whether or not there is more than
one oxygen sensor in the type I cell. Other possible oxygen sensors in the type I cell
include protein complexes of the mitochondrial electron transport chain (Nurse,
2005), an extra-mitochondrial rotenone-sensitive protein (Lopez-Barneo, 2003),
and a plasma membrane-associated heme oxygenase-2 (Wiliams et al., 2004).
The mechanisms by which type I cells respond to other stimuli, such as
hypercapnia and acidosis, have also been studied. Most research indicates that
hypercapnia causes a drop in intracellular pH which inhibits various acid-sensitive
K+ channels, such as TASK-1 and TASK-3 (Buckler & Vaughan-Jones, 1994; Buckler
et al., 2000). Inhibition of K+ channels causes a membrane depolarization, opens
voltage-gated Ca2+ channels, and initiates neurosecretion (Peers & Buckler, 1995).
Intracellular and extracellular pH play a role in type I cells response to acidic stimuli
(Buckler et al., 2000). The sensitivity of TASK-1 and TASK-3 channels to acid is due
to the protonation of a histidine residue in the large extracellular loop/helical cap
region (Kim et al., 2000; Morton et al., 2003; Rajan et al., 2000). However, the initial
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response of type I cells to hypercapnia is dependent on the activity of carbonic
anhydrase, which converts water and CO2 to bicarbonate (Gonzalez et al., 1994).
The mechanism of type I cells sensing low glucose levels has been less
studied. One study suggests that hypoglycemia sensing involves the inhibition of
voltage-dependent (but Ca2+-independent) K+ channels, causing a membrane
depolarization and neurotransmitter release (Lopez-Barneo, 2003). The released
neurotransmitter cause increase firing rates in the CSN, and then signal to the
nucleus tractus solitaries (NTS) of the medulla.
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Figure 3
Schematic of the membrane hypothesis for oxygen sensing. Through an unknown
mechanism, hypoxia inhibits oxygen sensitive K+ channels, such as TASK channels or
BKCa channels. The increase in cytoplasmic potassium increases the membrane
potential. The increase in membrane potential activates voltage-gated Ca2+
channels, allowing Ca2+ influx. The increase in cytoplasmic Ca2+ concentration
initiates vesicle fusion and neurotransmitter release.
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Neurotransmitters of Carotid Body Type I Cells
Several biogenic amines have been identified in the type I cells of the carotid
body. For an example, dopamine is abundant in the type I cell and has been well
characterized (Gonzalez et al., 1994). Type I cells express tyrosine hydroxylase
(TH), which is the rate-limiting enzyme in catecholamine biosynthesis (Nurse,
2005). Type I cells can be identified in immunocytochemistry experiments with TH
staining. Also, the biosynthetic enzyme histamine carboxylase, which is involved in
histamine synthesis, has been localized in type I cells from rat carotid bodies
(Koerner et al., 2004). Although the histamine concentration in type I cells has been
suggested to exceed that of dopamine by as much as 10 times, the functional role of
histamine in the carotid body remains unexplained (Nurse, 2005). However, there
is evidence that histamine may play an inhibitory role that opposes the excitatory
effects of acetylcholine (ACh) on type I cells (Thompson et al., 2010). Moreover,
type I cells also contains norepinephrine and serotonin (5-HT) (Nurse, 2005).
Many neurotransmitters are released from, and act upon the cells of the
carotid body in response to stimuli. For an example, ACh, adenosine, ATP, and
serotonin (5-HT) are excitatory neurotransmitters (Nurse & Piskuric, 2013). ACh
has been found to act postsynaptically on CSN fibers, as these fibers are directly
stimulated by ACh via nicotinic receptors (Iturriaga & Alcayaga, 2004; Fitzgerald,
2000). In addition, stimulation of nicotinic receptors on type I cells activates a
cation current, causing a membrane depolarization and increase in intracellular Ca2+
(Wyatt & Peers, 1993; Shirata et al., 2007). Adenosine plays an excitatory role in
ventilation due to its increase in chemosensory activity in the CSN (Conde et al.,
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2009). Also, purinergic (P2X) blockers were shown to inhibit hypoxic-induced
postsynaptic responses, supporting ATP’s role as an excitatory neurotransmitter
(Nurse, 2005; Nurse, 2010). Exogenous 5-HT has also been shown to have
stimulatory effects on the CSN (Nurse & Piskuric, 2013).
Inhibitory pre- and postsynaptic neurotransmitters that act on the carotid
body include GABA and dopamine (Nurse & Piskuric 2013). GABA agonists have
been shown to reduce the hypoxic ventilatory response in mammals by inhibiting
the CSN discharge (Kim et al., 2006; Shirahata, 2002). Dopamine receptor
antagonists have been shown to increase the ventilatory response to hypoxia in
rodents (Gonzalez et al., 1994; Iturriaga & Alcayaga, 2004; Shirata et al., 2007).

Effects of Somatostatin on Type I Cells and Breathing
SST has been localized within nerve fibers that innervate the arterial
chemoreceptors of guinea pigs, but the role of this peptide in those sensory fibers
has yet to be resolved (Kummer et al., 1990). Nevertheless, it has been shown that
SST depresses the acute hypoxic ventilatory response, as well as sensitivity to CO2 in
conscious humans (Pedersen et al., 1999). On a scale of tens of minutes, humans
infused with SST (0.5 mg•h-1; 0.06 μM) were found to have reduced acute hypoxic
ventilatory response by 82% and acute hypercapnic ventilatory response by 26%
(Pandit et al., 2014).
Similar effects were found when the drug was intravenously injected into
anesthetized rats. Rats infused with SST (100 μg•kg-1; 0.95 μM) had reduced tidal
volume and breathing frequency (Kaczyńska & Szereda-Prestaszewska, 2010).
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In SST studies involving the breathing of humans and rats, the inhibiting
mechanism of SST was hypothesized to be working at the level of the carotid body.
There is evidence of SST directly affecting type I cells. SST (0.1 μM) was shown to
reversibly inhibit whole cell Ca2+ current peaks by 24% in rat carotid body type I
cells (e Silva & Lewis, 1995). Inhibition of Ca2+ entry may change the
chemotransduction signal in type I cells, and partially account for the reductions in
acute hypoxic and hypercapnic ventilatory responses in humans infused with SST.
Although studies investigating the peripheral effects of SST on breathing
have been limited in number, there have been multiple studies assessing the central
effects. For an example, intracisternally injected SST in rats caused apnea
(Harfstrand et al., 1984). In cats, apnea occurred when SST was microinjected into a
region of the medulla oblongata known as the nucleus paragigantocellularis lateralis
(Yamamoto et al., 1988). Similarly in rats, microinjection of SST in the same area of
the medulla oblongata induced apnea (Chen et al., 1990). However, when SST was
microinjected into the rostral portion of the nucleus, the nucleus facialis, ventilatory
depression occurred rather than apnea (Chen et al., 1990). These studies
demonstrate the ability of SST to modulate central regulation of respiration. SST
has been suggested to affect respiration at three different levels of the central
respiratory network: 1) modulating the output of cranial and spinal motor neurons,
2) altering respiratory rhythmogenesis in the brainstem, and 3) regulating the
chemosensory drive to the respiratory pattern generator (Llona & Eugenín, 2005).
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Somatostatin
SST is a neuropeptide hormone that is distributed throughout the central and
peripheral nervous systems. It is a neurotransmitter and modulates neural activity.
It is naturally synthesized as an active peptide in two distinct forms: a 14-amino
acid peptide chain (SST-14) and a 28-amino acid peptide chain (SST-28). SST is
synthesized in various cells, such as neuroendocrine, inflammatory cells, and
immune cells, in response to neurotransmitters, ions, steroid hormones, growth
factors, cytokines, and nutrients (Patel, 1999). Both forms of the peptide act on
multiple tissues, including the brain, gut, pituitary gland, endocrine pancreas,
adrenal glands, kidneys, and immune cells (Patel & Srikant, 1997). Due to its
ubiquitous nature, SST carries out a broad spectrum of biological responses upon
binding to one of five SST receptor (SSTR) subtypes (Patel, 1999).
Plasma levels of SST vary among species, and even between individuals of the
same species. For an example, someone who has recently eaten a meal will
experience greater plasma SST levels than someone who has not. This is because
SST plays a significant role in the digestive tract, as it is a potent inhibitor of many
gastrointestinal hormones including gastrin, cholecystokinin, and secretin (Krejs,
1986). One study has measured normal human subjects to have fasting plasma SST
concentrations of 13.3 pg•ml-1 (8.12 pM) on average (Saito & Saito, 1982). In
addition to eating a meal, SST-secreting tumors can also alter plasma SST levels
among individuals. Patients with carcinoma had plasma concentrations of SST
ranging from 125 pg•ml-1 (80 pM) to 400 pg•ml-1 (244 pM), and a patient with
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pheochromocytoma exhibited a SST concentration 47.0 pg•ml-1 (28.9 pM) in the
plasma (Saito & Saito, 1982).

Somatostatin Receptors
In humans, SSTRs are encoded by five nonallelic genes located on different
chromosomes (Patel & Srikant, 1997). Four of the genes contain no introns, with
one exception: Splice variants of SSTR2 can give rise to SSTR2A and SSTR2B, which
only differ in cytoplasmic C-tail length (Patel & Srikant, 1997). Moreover, there is a
great degree of structural conservation in SSTRs among different species. Between
humans and rats SSTR1 isoforms, there is 94-98% sequence identity, 93-96% for
SSTR2, 88% SSTR4, and 82-83% for SSTR3 and SSTR5 (Patel & Srikant, 1997).
In order for SST to carry out its role, whether in neurotransmission,
secretion, or cell proliferation, it must first bind to a family of five SSTR subtypes
(SSTR1-5). SSTR1-5 have a seven transmembrane domain. Also, these receptors
were identified to be G-protein coupled receptors (Yamada et al., 1992). All
receptor subtypes bind to SST with great affinity, typically in the low nanomolar
range (0.1-7.9 nM) (Patel & Srikant, 1994). SSTR1-4 have slightly higher affinity for
SST-14, while SSTR5 has a greater affinity for SST-28 (Patel & Srikant, 1997).
However, since SST-14 and SST-28 have great length and flexibility, both peptides
can adopt the correct conformation allowing entry into any of the five SSTR subtype
binding pockets (Patel & Srikant, 1997).
Upon binding to any of the five SSTRs, SST initiates G-protein coupled
signaling cascade (Figure 4). SSTR activation is associated with decreases
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intracellular cyclic AMP (cAMP) and Ca2+ concentrations, and stimulation of protein
phosphatases (Patel & Srikant, 1997). Therefore, SSTR1-5 work via a Gi-protein
coupled mechanism (Patel & Srikant, 1997).
Once activated after SST binding, the receptor then activates a pertussis
toxin-sensitive GTP-binding protein, which inhibits adenylyl cyclase activity.
Adenylyl cyclase causes a decrease in intracellular cAMP levels, which inhibits PKA
activation and protein phosphorylation. SSTRs are also coupled to K+ channels, such
as the BKCa, delayed rectifier, and ATP-sensitive K+ channels (Patel et al., 1995;
Reisine & Bell, 1995). SSTR activation causes K+ channels to hyperpolarize the cell
membrane potential, inhibiting spontaneous action potentials. Also, this
hyperpolarization causes a reduction in intracellular Ca2+ levels due inhibition of
voltage-gated Ca2+ channels (Patel & Srikant, 1997). At the level of the type I cell,
SST has been suggested to affect dihydropyridine-sensitive L-type Ca2+ channels and
ω-conotoxin GVIA-sensitive N-Type Ca2+ channels (e Silva & Lewis, 1995).
Excitatory neurotransmitter normally depolarizes the cell membrane, which opens
voltage-gated Ca2+ channels and induces a Ca2+ influx. But with no Ca2+ influx,
vesicles will not be able to fuse with the membrane, neurotransmitter will not be
released, and signaling from the excitable cell will be inhibited.
Other mechanisms have been studied to explain the inhibition of Ca2+
currents. For an example, SSTRs have been shown to activate protein phosphatases,
such as the Ca2+-dependent phosphatase calcineurin (Renström et al., 1996), protein
tyrosine phosphatases (Florio et al., 1994), and serine threonine phosphatases
(White et al., 1991). Serine threonine proteases dephosphorylate Ca2+ channel

20

proteins, and activate K+ channel proteins, thus hyperpolarizing the cell and
inhibiting Ca2+ influx (Patel & Srikant, 1997).
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Figure 4
Illustration of SST’s mechanism in modulating cell secretion. SST binding to any
SSTR subtype stimulates the Gi signaling pathway. Activation of a pertussis toxinsensitive GTP-binding protein initiates three major effector pathways involving
adenylyl cyclase (AC), K+ channels, or protein phosphatases. The downstream
effects of these three pathways include a decrease in intracellular cAMP, a decrease
in intracellular Ca2+, and an increase in calcineurin. The SST-dependent activation
and increase in calcineurin, along with decreases in cAMP and Ca2+, block exocytosis
and inhibit cell secretion.
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Hypothesis and Summary
The purpose of this study was to investigate the possible inhibiting
mechanism of SST on the hypoxic and hypercapnic responses of type I cells from
neonatal rat carotid bodies. Studies have shown that SST alters breathing, so this
project was aimed at characterizing the effects of SST on voltage-gated Ca2+ influx in
type I cells. The hypothesis of this study was that SST inhibits voltage-gated Ca2+
entry into isolated type I cells, and thus inhibits the acute hypoxic and hypercapnic
ventilatory responses.
First, immunocytochemistry staining was performed to identify SST and
SSTR1-5. Once identified, it had to be determined if SST and its receptors were
functional. This was done by testing the excitability of type I cells and recording
intracellular Ca2+ levels. The effect of SST on voltage-gated Ca2+ influx was
measured using Ca2+ imaging. Voltage-gated Ca2+ channels were studied using a
high potassium stimulus, which evokes a robust Ca2+ influx in type I cells. A
physiological stimulus, hypoxia, was also used to test the effects of SST on the
hypoxic response. Intracellular Ca2+ levels were measured using hypoxia to evoke
voltage-gated Ca2+ entry into the type I cell. Since humans infused with SST also had
a reduced hypercapnic ventilatory response, the effect of SST on the acid-induced
depolarization of type I cells was also recorded. This was done using the perforated
patch clamp technique to measure the membrane potential of type I cells.
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MATERIALS AND METHODS
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Dissection and Dissociation of Neonatal Rat Carotid Body Type I Cells
On each experimental day, three neonatal Sprague Dawley rats (12-19 days
old) were placed, one at a time, in an induction chamber. In the chamber, animals
were anesthetized with 4.5% isofluorane and 95.5% oxygen at a flow rate of 0.9
L•min-1. Once the animal was unconscious, it was transferred to a nose cone
underneath a dissecting microscope. The rat in the nose cone was exposed to the
same anesthetic gas and flow rate as in the induction chamber. The animals were
checked to be completely unconscious by testing their withdrawal reflex using a foot
and tail pinch. Once the rat had no response to the pinch, its limbs were taped down
to keep it stationary, and the dissection was carried out.
Each dissection started with an incision made along the rat’s sternum to
expose subcutaneous fascia. After this initial incision, a low magnification dissecting
microscope (Omâno, Japan) was used for the remainder of the dissection. The
fascia, salivary glands, fat tissue, and skeletal muscles lateral to the trachea were
removed using fine forceps (Dumont Inox #5, Fine Science Tools), in order to view
the common carotid artery. Any fat tissue and fascia still attached to the common
carotid artery was carefully removed so that the bifurcation of the carotid artery
was exposed. The hypoglossal nerve, which runs across the carotid artery, was cut
and spread away from the bifurcation. The occipital artery, connected to the carotid
artery, was then cut and proximally reflected exposing the internal carotid artery,
where the carotid body is located. Using fine-tipped forceps, the carotid body was
carefully removed from the connective tissue surrounding the internal carotid
artery and placed directly in iced Dulbecco’s phosphate buffered saline (DPBS)
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without calcium or magnesium (Sigma). While rats were still anesthetized, they
were euthanized by decapitation and disposed of in accordance with Lab Animal
Research requirements. The extracted carotid bodies were then examined under
the Omâno microscope and any remaining excess tissue that adhered to the carotid
body was removed.
Once excess tissue was removed, the carotid bodies were transferred to a
separate Petri dish containing a digestive enzymatic solution (0.4 mg•ml-1
collagenase type I (Worthington), 0.2 mg•ml-1 trypsin type I (Sigma)) in DPBS with
low calcium and magnesium. They were incubated at 37°C for 20 minutes to digest
the connective tissue holding the organ together. The carotid bodies were then torn
apart using fine forceps and incubated at 37°C for an additional 7 minutes. Next, the
tissue was transferred to a 15 ml centrifuge tube where it was centrifuged at 130 g
for 5 minutes. The tissue was resuspended in Ham’s F-12 culture medium,
containing L-glutamine and NaHCO3 (Sigma). After another 5 minute centrifugation,
the digested tissue was triturated with a fire polished Pasteur pipette (Sigma). The
cells were then plated onto 4 to 6 polylysine-coated coverslips and kept in Petri
dishes and incubated at 37°C for 2 hours. After this incubation period, the cells
were ready for experiments.

Dissection and Dissociation of Adult Rat Carotid Body Type I Cells
On experimental days with adult rats, two Sprague Dawley rats (150 g, 6-8
weeks old) were used. The dissection procedure was similar to that of neonatal rats
with a few important differences. First, instead of using anesthesia, adult rats were
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euthanized using a rising concentration of CO2. In addition, due to the increased
amount of connective, adipose, and nervous tissue in the adult rat, the carotid body
was not directly taken off the bifurcation in the animal. The common carotid artery
and the occipital artery were cut and removed from the animal with the bifurcation
still intact. The extracted bifurcations were examined under the Omâno microscope
and any excess connective and nervous tissue was removed. Once excess tissue was
cleared from the bifurcation, the carotid body was carefully taken from the
bifurcation. The remaining dissociation steps were identical to that of the neonatal
rats, except the carotid bodies were incubated in the digestive enzymatic solution,
containing 0.45 mg•ml-1 collagenase type I and 0.25 mg•ml-1 trypsin, for 25 minutes
at 37°C.

Immunocytochemistry
Isolated type I cells adhered onto 22 X 22 mm square coverslips (Fisher
Scientific) were fixed by immersion in methanol at -20°C for 15 minutes. The
coverslips were tilted using fine forceps to remove excess solution from the top of
the coverslip. Cells were then washed 3 x 5 minutes with 0.4 ml Blocking Solution
(1% BSA (Sigma), 0.3% Triton-X 100 (Alfa Aesar), and phosphate buffered saline
(PBS) (Sigma)). Anti-SSTR primary antibodies were used to identify the presence of
SSTR1-5 on the membrane and in the cytoplasm of type I cells, while an anti-TH
antibody was used to verify the cells were type I cells (Figure 5A).
The anti-SSTR1 primary antibody (ThermoFisher: PA3-206) was a rabbit
polyclonal diluted in blocking solution 1:5000. Anti-SSTR2-5 primary antibodies
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(Alomone Labs: ASR-006, ASR-003, ASR-004, ASR-005) were all rabbit polyclonal
and diluted to 1:50 in blocking solution. The anti-TH primary antibody (Sigma) was
mouse monoclonal and diluted to 1:1000 in blocking solution. Anti-SSTR and antiTH primary antibodies were added to appropriate coverslips and incubated at 4°C
overnight in a humidified chamber. Control coverslips contained no primary
antibodies, only blocking solution.
After the incubation, the coverslips were washed in 0.4 ml blocking solution
2 x 10 minutes. The secondary antibodies were added to all coverslips and
incubated in the dark at room temperature for 2 hours. Before the secondary
antibodies were applied, they were centrifuged in blocking solution for two minutes
at 1100 rpm. Rhodamine Red-X conjugated AffiniPure donkey-anti rabbit IgG
secondary antibody (Jackson ImmunoResearch) was diluted to 1:200 in blocking
solution and used to label SSTR1-5. Fluorescein (FITC)-conjugated AffiniPure
donkey anti-mouse IgG secondary antibody (Jackson ImmunoResearch) was diluted
to 1:200 in blocking solution and used to identify TH in the cytoplasm of type I cells.
Coverslips were again washed in blocking solution 3 x 5 minutes. Vectashield
mounting media (15 μl, Vector Laboratories) was placed on the microscope slide.
The DAPI in the Vectashield stained the nucleus of the cells. After the coverslips
were tilted to remove excess solution, they were placed faced down on the
Vectashield. The coverslips were sealed with nail polish, placed in a slide box, and
incubated in the dark at 4°C overnight. The first SSTR immunocytochemistry
experiments are summarized in Figure 5B.
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The DeltaVision microscope system (Applied Precision) on an inverted
Olympus IX71 microscope was used to obtain images. The microscope contained an
oil immersion, x63 magnification, 1.4 n.a. objective and Coolsnap HQ CCD camera
(Photometrics). Each image was scaled to have a width of 15 μm. Images were set
for RD TR PE 617/73 nm emission and 555/28 excitation (Percent Transmission
(%T) = 50% and exposure = 0.100 s), FITC 528/38 nm emission and 490/20
excitation (%T = 32% and exposure = 0.100 s), and DAPI 457/50 nm emission and
360/40 excitation (%T = 100% and exposure = 0.050 s). As pictures were being
taken, multiple Z-sections were also taken throughout the cell. Each Z-section was
0.25 μm apart, and the focal depth was 0.28 μm. All images were deconvolved with
Softworx software (Applied Precision).
Due atypical perinuclear TH staining, a second SSTR immunocytochemistry
experiment was performed using a new, unopened anti-TH primary antibody. The
secondary antibodies were diluted 1:1000 in blocking solution in this experiment.
The second set of experiments are summarized in Figure 5C.
The same procedure was also repeated for an anti-SST antibody (Sigma:
SAB4502861). Anti-SST staining experiments are summarized in Figure 5D.
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Figure 5
Staining in isolated type I cells from neonatal rats using double
immunofluorescence. A) Illustration of 1° antibodies identifying SSTR, SST, and TH.
The fluorescently labeled 2° antibodies bind to the 1° antibodies. SSTR and SST
were stained red with Rhodamine and TH was stained green with FITC. B) Table
summarizing the first set of SSTR immunocytochemistry experiments. C) Summary
of second set of SSTR immunocytochemistry experiments. New anti-TH antibody
was used and the 2° antibodies were diluted 1:1000. D) Summary of anti-SST
immunocytochemistry experiment.
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A)

B)
Target
SSTR 1
SSTR 2-5
TH
C)
Target
SSTR 1
SSTR 2-5
TH
D)
Target
SST
TH

Antibody
1° rabbit anti-rat
2° donkey anti-rabbit
1° rabbit anti-rat
2° donkey anti-rabbit
1° mouse anti-rat
2° donkey anti-mouse

Dilution
1:5000
1:200
1:50
1:200
1:1000
1:200

Fluorophore Color

Antibody
1° rabbit anti-rat
2° donkey anti-rabbit
1° rabbit anti-rat
2° donkey anti-rabbit
1° mouse anti-rat
2° donkey anti-mouse

Dilution
1:5000
1:1000
1:50
1:1000
1:1000
1:1000

Fluorophore Color

Antibody
1° rabbit anti-rat
2° donkey anti-rabbit
1° mouse anti-rat
2° donkey anti-mouse

Dilution Fluorophore Color
1:100
Rhodamine
Red
1:200
1:1000
FITC
Green
1:200
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Rhodamine

Red

Rhodamine

Red

FITC

Green

Rhodamine

Red

Rhodamine

Red

FITC

Green

Solutions
For the first set of Ca2+ imaging experiments, HEPES buffered salt solution,
adjusted to pH 7.4 with NaOH at 35-37°C, was used as the extracellular solution.
HEPES buffered salt solution contained the following concentrations (in mM): 140
NaCl, 4.5 KCl, 2.5 CaCl2, 1 MgCl2, 11 glucose, and 10 HEPES (NaCl and CaCl2 Fisher
Scientific, all others Sigma). The high potassium stimulus (80 mM K+) was HEPES
buffered salt solution adjusted to pH 7.4 with KOH at 35-37°C, and contained the
following concentrations (in mM): 64.5 NaCl, 80 KCl, 2.5 CaCl2, 1 MgCl2, 11 glucose,
and 10 HEPES. The hypoxic stimulus was made by bubbling HEPES buffered salt
solution with 100% N2 and adding 1 mM sodium dithionate (Fluka) to scavenge O2.
The next set of Ca2+ imaging experiments involving hypoxia used Tyrode’s
solution at 35-37°C as the extracellular solution, and contained the following
concentrations (in mM): 117 NaCl, 4.5 KCl, 11 glucose, and 23 NaHCO3 (Sigma).
CaCl2 (2.5 mM) and MgCl2 (1 mM) was added after bubbling in 5% CO2 and 10% O2
for 15 minutes, to prevent calcium carbonate and magnesium carbonate formation.
The control solution was gassed with 5% CO2 and 10% O2. The hypoxic stimulus
was made by bubbling Tyrode’s solution in 95% N2 and 5% CO2 and adding 1 mM
sodium dithionate to scavenge O2.
Electrophysiology experiments used the same hypoxic and control HEPES
buffered salt solutions as described in the first Ca2+ imaging experiments, with an
additional acidic stimulus. An acidic HEPES buffered salt solution was made as
previously described, but it was adjusted to pH 6.9 with NaOH.
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Perforated Patch Clamp
Isolated type I cells adhered onto 15 mm diameter round coverslips (Warner
Instruments) were mounted in a perfusion chamber (0.4 ml, RC-25F, Warner
Instruments) and perfused with extracellular solution at a rate of 8 ml•min-1. Cells
were viewed using the Nikon Eclipse TE 2000U inverted microscope. Recordings
were made using the amphotericin perforated patch configuration of the whole-cell
patch clamp technique (Figure 6). Data were acquired using an Axopatch 200B
amplifier (Molecular Devices) controlled by Clampex 10 (Molecular Devices).
Currents were sampled at 2 kHz and filtered at 1 kHz. All data were analyzed using
Clampfit 10 software (Molecular Devices). All experiments were completed on an
anti-vibration microscopy table (TMC) and performed in the range of 35-37°C.
Pipettes were made from 1.5 OD x 0.86 ID x 100 L mm glass capillaries
(Harvard Apparatus). The ends of the glass capillaries were polished by placing
over a flame from a methanol lamp. Once cooled, the pipettes were pulled using the
Narishige Model PC-10 (Narishige Group). Pipette tips with a resistance of 6.5-9.5
MΩ were used in experiments. Pipettes were half-filled with 250 μg•ml-1
amphotericin B (Sigma), then placed on the Ag/AgCl electrode wire. The electrode
wire was mounted on a motorized micromanipulator (Sutter Instrument Company).
The pipette tip was carefully lowered into the extracellular solution of the perfusion
chamber using the motorized micromanipulator. Once the tip contacted the cell
membrane, suction was slowly applied to form a gigaseal, allowing electrical access
to the cell.
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After allowing 5 minutes for amphotericin B to perforate the cell, the seal
was checked. When a stable patch was obtained with a seal resistance greater than
2 GΩ, the membrane potentials of type I cells were recorded. After a stable baseline
membrane potential reading, cells were exposed to the acidic HEPES buffered salt
solution which caused a depolarization. Once the cell recovered to its initial
baseline membrane potential, the cell was exposed to 1 μM SST (Sigma: S9129) for 2
minutes. The cell was then exposed to the acidic stimulus again in the presence of 1
μM SST.
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Figure 6
Schematic showing the setup for electrophysiology experiments.
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Calcium Imaging Experiments with FURA-2
Isolated type I cells adhered to 15 mm diameter round coverslips were
loaded with a Ca2+-sensitive ratiometric dye, FURA-2AM (Invitrogen), in a Petri dish
at room temperature. The cells were loaded for 30 minutes in the dark to allow the
dye to penetrate the cells. For Ca2+ imaging experiments using a high potassium
stimulus, the loading solution contained 5 μM FURA-2AM in HEPES buffered salt
solution adjusted to pH 7.4. For Ca2+ imaging experiments using a hypoxic stimulus,
the loading solution contained 5 μM FURA-2AM in Ham’s F-12 culture medium and
was gassed at room temperature with 10% O2 and 5% CO2. FURA-2AM is a dye
commonly used in Ca2+ imaging experiments and has ratiometric properties that
avoid bleaching artifacts. After the loading period, the coverslips were washed
twice in either pH 7.4 HEPES buffered salt solution (high potassium experiments) or
Ham’s F-12 culture medium (hypoxic experiments) in the dark for 10 minutes each
to ensure that the –AM groups from the dye were cleaved.
The coverslips were then mounted in a perfusion chamber and perfused with
extracellular solution at a rate of 8 ml•min-1. Cells were viewed using the Nikon
Eclipse TE 2000U inverted microscope with a CFI super fluor x40 oil immersion
objective. Cells were excited with 50 ms exposures to 340 nm and 380 nm light at
0.2-0.5 Hz using a Lambda 10-3 filter wheel (Sutter Instrument Company). The light
traveled from the lamp source, through a neutral density filter (Chroma), and
reflected from a 400 DCLP dichroic mirror (Chroma) up to the cells. The light from
the high wattage lamp source (Lambda-LS xenon arc lamp, Sutter Instrument
Company) first passed through neutral density filters with optical densities of 0.7,
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before reaching the cells to prevent photodamage. When the light reached the cells,
they emitted fluorescent light, which was brightest 510 nm. This light was then
reflected through the dichroic mirror, bent 90°, and traveled through a 510 nm ± 30
nm filter. The light that passed through the 510 nm filter (Chroma) was recorded
using a Coolsnap HQ2 CCD camera (Photometrics) (Figure 7). Image acquisition
was controlled by Metafluor 7.1.2 software (Molecular Devices). A spherical region
of interest was placed around the cells so that the software could graph the 340/380
fluorescent ratios over time.
In the first set of Ca2+ imaging experiments, cells were perfused with HEPES
buffered salt solution. A high potassium stimulus was used to evoke an increase in
voltage-gated Ca2+ influx in the neonatal rat isolated type I cells. The large increase
in cytoplasmic Ca2+ levels in response to the high potassium stimulus indicated type
I cells. Cells were then exposed to 1 μM SST for 2, 10 and 20 minutes, and then
exposed to the high potassium stimulus again. Initially, cells were exposed to 0.1
μM, but since no inhibition was evident, the concentration for SST was increased by
a factor of 10 for remaining experiments. This Ca2+ imaging experiments was
repeated in isolated type I cells from adult rats using the high potassium stimulus.
In experiments with adult rats, the effect of a 2 minute exposure of 1 μM SST was
measured. The procedure was identical to the first set of Ca2+ experiments on
neonatal rat type I cells.
The next set of Ca2+ imaging experiments measured the effects of a 2 minute
exposure of 1 μM SST on the hypoxic response in isolated type I cells from the
neonatal rat carotid body. Due to the cells instability and lack of responsiveness to a
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hypoxic HEPES buffered salt solution, a hypoxic Tyrode’s solution was used. With
the exception of the bathing solutions, the procedure was similar to the first set of
Ca2+ experiments. Ca2+ imaging on the hypoxic response was also repeated for a
longer time frame: 10 and 20 min SST exposures. The hypoxic Ca2+ imaging
experiments with 10 and 20 minute exposures were identical to the first set of
hypoxic Ca2+ imaging experiments.
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Figure 7
Schematic showing the setup for calcium imaging experiments.
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Oxygen Measurements in Solutions
PO2 was measured in control and hypoxic HEPES buffered salt solutions using
OxyMicroDevice (World Precision Instruments, Inc.). The male fiber-optic plug was
connected to the ST-plug of the OxyMicroDevice. The spring of the male fiber-optic
plug of the microsensor was inserted into the groove of the female fiber-optic plug.
A safety nut was carefully turned to ensure the fiber-optic plug was locked into the
OxyMicroDevice. The other end of the fiber-optic cable contained the syringe and
microsensor. The oxygen-sensitive needle-type microsensor was housed in a 0.4 x
40 mm syringe needled mounted to a 1 ml plastic syringe.
The protective plastic cap was carefully removed to expose the syringe
needle. The syringe needle was placed above the perfusing HEPES buffered salt
solution, with the glass fiber retracted. Then, the glass fiber with the microsensor
tip was completely extended from the syringe needle by carefully pressing the
syringe plunger so that the tip was submerged in the solution. The microsensor is
based on luminescence quenching caused by collisions between luminescent dye
molecules in the excited state and molecular oxygen. In the presence of oxygen, a
collision occurs where energy is transferred from the excited indicator molecule (on
microsensor) to oxygen. Oxygen therefore changes from its ground state into an
excited state. This makes the indicator molecule unable to emit luminescence, and
its luminescence signal decreases. In the absence of oxygen, the excited indicator
molecule does not collide with oxygen. Since no collisions occur, the excited
indicator molecule remains in the excited state, emits luminescent light, and has a
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measurable luminescence signal that is greater than the signal when oxygen is
present.
After the oxygen level was recorded in the control HEPES buffered salt
solution, the solution was changed to the hypoxic solution and the oxygen level was
recorded (Figure 8). When finished, the glass fiber with the microsensor tip was
rinsed with distilled water to remove any sample residues. The microsensor tip was
then retracted into the protective housing and the plastic cap was placed back on
the syringe.
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Figure 8
Measuring PO2 levels in control and hypoxic solutions using OxyMicroDevice. The
initial PO2 in control solution is 140 torr. When the control solution is switched to
the hypoxic solution (100% N2), the PO2 descended from 140 torr to 20 torr in a
minute, and it took another minute for the PO2 to reach under 10 torr. When
switched back to the control solution, the PO2 recovered to 140 torr in a minute.
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Statistics
Data are presented as mean ± standard error of the mean. Differences
between individual means were determined by an unpaired Student’s t test, and
statistical significance was indicated by values of p<0.05.
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RESULTS
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Immunocytochemistry
Staining for SSTRs in Isolated Type I Cells
SSTR1-5 were qualitatively identified on isolated type I cells from the carotid
bodies of neonatal rats using double immunofluorescence. Five distinct rabbit antirat primary antibodies were used to characterize all five SSTR. Receptors were
stained red with the secondary antibody containing Rhodamine. TH, which
indicates type I cells, was stained green with the secondary antibody containing
FITC. DAPI stained the nucleus blue. In control experiments, the cells were not
exposed to primary antibodies, only secondary antibodies.
Staining results show SSTR1-5 are all present cytoplasmically within the type
I cell, with SSTR1 also appearing on the cell membrane (Figure 9). The control
image, containing no primary antibodies, shows only the nucleus from DAPI
staining. This indicates that there was no non-target binding of the secondary
antibodies. All images show green staining of TH, marking the cells as type I cells.
However, the TH staining appears abnormally perinuclear. TH staining is typically
more obvious in the cytoplasm, because anti-TH antibodies should be present in
cytoplasmic vesicles containing dopamine. The first set of immunocytochemistry
experiments used an old anti-TH antibody, which might have accounted for the
perinuclear staining.
The staining procedure was repeated for a second set of experiments. To
account for the abnormal TH staining in the previous experiment, a new primary
anti-TH antibody was used, and the dilutions for all secondary antibodies was
1:1000 instead of 1:200. The images show that SSTR1-5 are all present in the
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cytoplasm (Figure 10). There is some TH staining in the cytoplasm, but it is
predominantly perinuclear again. Because the sources of the primary and
secondary antibodies were the same as the first experiment, no control image is
shown in this figure; refer to Figure 9 for a control image.

Staining for SST in Isolated Type I Cells
Type I cells were also stained for SST using a rabbit anti-rat primary
antibody. SST red was stained red with Rhodamine, TH was stained green with
FITC, and the nucleus was stained blue with DAPI. The image shows that SST is
present throughout the cytoplasm and membrane in type I cells (Figure 11).
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Figure 9
SSTR staining in isolated neonatal rat carotid body type I cells using double
immunofluorescence. SSTR1-5 are all present in the cytoplasm in type I cells.
SSTR1 staining also suggests that the receptor may be present on the membrane.
SSTRs are stained red with Rhodamine. TH, indicating a type I cell, is stained green
with FITC. The nucleus of the cells are stained blue with DAPI. Scale bar is 10
microns.
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Figure 10
Repeated SSTR staining in isolated neonatal rat carotid body type I cells using
double immunofluorescence. SSTR1-5 are all present cytoplasmically in type I cells.
SSTRs are stained red with Rhodamine. TH, indicating a type I cell, is stained green
with FITC. The nucleus of the cells are stained blue with DAPI. Secondary
antibodies were diluted 1:1000. Scale bar is 10 microns.
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Figure 11
SST staining in isolated neonatal rat carotid body type I cells using double
immunofluorescence. SST is present in the cytoplasm and membrane of type I cells.
The secondary antibodies used were the same as those used when staining for
SSTRs, refer to Figure 9 for control staining. Scale bar is 10 microns.
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Calcium Imaging
High K+ Stimulus in Neonatal Rat Carotid Body Type I Cells
The effect of SST on voltage-gated Ca2+ influx was measured using Ca2+
imaging with FURA-2. A high potassium stimulus was used to open voltage-gated
Ca2+ channels, evoking an increase in intracellular Ca2+ levels. The high potassium
stimulus was used to indicate healthy type I cells. Cells that did not respond to the
high potassium stimulus were not used for recordings, because this meant the cell
was either damaged or not a type I cell.
Cells that had a robust response to high potassium were quickly placed in
control HEPES buffered salt solution and recovered to baseline Ca2+ levels. On
average, cells had an initial baseline Ca2+ 340/380 ratio of 0.578 (n=18). Once
baseline levels were reached cells recovered for an additional 2 minutes, and then
exposed to the high potassium stimulus again (Figure 12A). In experiments with
SST, once baseline Ca2+ levels were reached, the cells recovered for 2 minutes in
HEPES buffered salt solution containing 1 μM SST (Figure 12B). After the 2 minute
recovery, cells were exposed to the high potassium stimulus in the presence of 1 μM
SST.
The first Ca2+ peak was compared to the smaller second Ca2+ peak, and this
difference was measured as the percent inhibition (Figure 12C). FURA-2
fluorescence ratios show no significant Ca2+ inhibition for type I cells exposed to 1
μM SST for 2 minutes compared to controls (p=0.53). Control cells had an average
inhibition of 9.3 ± 2.9% inhibition (n=8). Cells exposed to 1 μM SST had an average
inhibition of 7.1 ± 2.1% inhibition (n=10).
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Figure 12
Effect of 2 minute exposure of 1 μM SST on K+ evoke Ca2+ currents in isolated type I
cells from the carotid body of neonatal rats using Ca2+ imaging. A) Control with 2
minute recovery in HEPES buffered salt solution. B) 2 minute recovery in 1 μM SST
and HEPES buffered salt solution. C) Histogram showing the percent inhibition of K+
evoked Ca2+ influx for type I cells (p>0.05, error bars are standard error of the
mean).
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This experiment was repeated with longer SST exposures to test if the
mechanism of 1 μM SST took longer than 2 minutes to have an effect on the type I
cell. The cells used in the experiments with 10 and 20 minute exposures of 1 μM
SST had an average initial baseline Ca2+ 340/380 ratio of 0.578 (n=22). In control
experiments, cells were initially exposed to high potassium, opening voltage-gated
Ca2+ channels and thus causing a Ca2+ influx. The cells then recovered to the
baseline Ca2+ level. 10 minutes after baseline Ca2+ levels were reached, the cells
were exposed to high potassium, and then again after 20 minutes (Figure 13A). In
experiments with SST, cells were exposed to 1 μM SST during the 10 and 20 minute
recoveries, and exposed to 1 μM SST in the presence of the high potassium stimulus
(Figure 13B).
The 10 and 20 minute Ca2+ peaks were separately compared with the initial
potassium induced Ca2+ peak (Figure 13C). FURA-2 fluorescence ratios show no
significant Ca2+ inhibition for type I cells exposed to 1 μM SST when compared to
controls, for both 10 minutes (p=0.22) and 20 minutes (p=0.10). Control cells had
an average inhibition of 12.2 ± 1.5% after 10 minutes (n=12), while cells exposed to
1 μM SST had an average inhibition of 15.5 ± 2.2% after 10 minutes (n=10). After 20
minutes, control cells had an average inhibition of 22.6 ± 2.1%, and cells exposed to
1 μM SST had an average inhibition of 28.6 ± 2.9%.
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Figure 13
Effect of 10 and 20 minute exposures of 1 μM SST on K+ evoked Ca2+ influx in
isolated type I cells from the carotid body of neonatal rats using Ca2+ imaging. A)
Control with 10 and 20 minute recovery in HEPES buffered salt solution. B) 10 and
20 minute recovery in 1 μM SST and HEPES buffered salt solution. C) Histogram
showing the percent inhibition of K+ evoked Ca2+ influx for type I cells (p>0.05, error
bars are standard error of the mean).
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Hypoxic Stimulus in Neonatal Rat Carotid Body Type I Cells
To test whether SST has an effect on the hypoxic response in type I cells, Ca2+
imaging was repeated using a hypoxic stimulus. Type I cells were exposed to a 2
minute application of 1 μM SST and the change in intracellular Ca2+ levels were
recorded using FURA-2. The cells were bathed in Tyrode’s solution for all hypoxic
experiments. Initially, cells were exposed to a hypoxic Tyrode’s solution, and if
hypoxia evoked an intracellular Ca2+ increase, then the cell was a type I cell. Only
cells that responded to hypoxia were used for this experiment.
Cells were used for recording if they had a robust response to hypoxia during
a 2 minute exposure. The cells used in this hypoxic Ca2+ imaging experiment had an
average initial baseline Ca2+ 340/380 ratio of 0.56 (n=32). During the first hypoxic
stimulus in control experiments, cells had an average fluorescence ratio increase of
0.53 ± 0.05 (n=15). After the initial stimulus, the cells recovered in Tyrode’s
solution to allow cytoplasmic Ca2+ levels to return to baseline. After 5 minutes from
the point when baseline was reached, the cells were exposed to the hypoxic stimulus
again for 2 minutes (Figure 14A). During the second hypoxic stimulus in control
experiments, cells had an average fluorescence ratio increase of 0.50 ± 0.04.
In experiments with 1 μM SST, the average fluorescence ratio increase during
the initial hypoxic stimulus was 0.77 ± 0.06 (n=16). Once baseline Ca2+ were
reached from the 2 minute stimulus, the cells recovered in Tyrode’s solution for 3
minutes. After 3 minutes, the cells were exposed to Tyrode’s solution containing 1
μM SST for 2 minutes, and then the hypoxia solution containing 1 μM SST for an
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additional 2 minutes (Figure 14B). During the second hypoxic exposure, in the
presence of 1 μM SST, cells had an average fluorescence ratio increase of 0.70 ± 0.06.
The average fluorescence ratio of the first hypoxic response was compared to
the average fluorescence ratio of the second hypoxic response. This difference was
measured as percent inhibition (Figure 14C). FURA-2 fluorescence ratios show no
significant Ca2+ inhibition for type I cells exposed to 1 μM SST for 2 minutes
compared to controls (p=0.64). Control cells had an average inhibition of 14.2 ±
2.7% (n=15). Cells exposed to 1 μM SST for 2 minutes had an average inhibition of
12.5 ± 2.2% (n=16).
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Figure 14
Effect of 2 minute application of 1 μM SST on the hypoxic response of isolated type I
cells from the carotid body of neonatal rats using Ca2+ imaging. A) Control with 5
minute recovery in Tyrode’s solution. B) 3 minute recovery in Tyrode’s solution,
then 2 minute exposure to Tyrode’s solution containing 1 μM SST. C) Histogram
showing the percent inhibition of hypoxic evoked Ca2+ influx in type I cells (p>0.05,
error bars are standard error of the mean).
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To test the effects of longer exposures of SST on the hypoxic response, Ca2+
was repeated with 10 and 20 minute exposures of 1 μM SST using a hypoxic
stimulus. To identify type I cells, the cells were initially exposed to a hypoxic
Tyrode’s solution. Only the cells that had a responded to hypoxia were used for this
experiment.
The cells used in this hypoxic Ca2+ imaging experiment had an average initial
baseline Ca2+ 340/380 ratio of 0.49 (n=23). During the first hypoxic stimulus in
control experiments, cells had an average fluorescence ratio increase of 0.72 ± 0.07
(n=8). Once baseline Ca2+ levels were reached from the initial stimulus, the cells
recovered in Tyrode’s solution for 10 minutes (Figure 15A). At the 10 minute mark,
the cells were exposed to the hypoxic stimulus again for 2 minutes. Cells had an
average fluorescence ratio increase of 0.67 ± 0.06 during the hypoxic stimulus at 10
minutes. After 20 minutes from the Ca2+ baseline recovery point from the initial
hypoxic stimulus, the cells were exposed to hypoxia for 2 minutes a final time.
During the third hypoxic exposure, at 20 minutes, cells had an average fluorescence
increase of 0.56 ± 0.05.
In experiments with 1 μM SST, the average fluorescence ratio increase during
the initial hypoxic stimulus was 0.84 ± 0.04. Once baseline Ca2+ were reached from
the initial 2 minute stimulus, the cells recovered in Tyrode’s solution with 1 μM SST
for 10 minutes (Figure 15B). After 10 minutes, the cells were exposed to a hypoxic
Tyrode’s solution containing 1 μM SST for 2 minutes. Cells had an average
fluorescence ratio increase of 0.77 ± 0.04 (n=15) during the hypoxic stimulus at 10
minutes. A second hypoxic Tyrode’s solution with 1 μM SST was applied to the cells
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20 minutes after the initial hypoxic response. Cells had an average fluorescence
ratio increase of 0.75 ± 0.05 (n=12) during the hypoxic stimulus at 20 minutes.
The average fluorescence ratio of the first hypoxic response was compared to
the average fluorescence ratio of the hypoxic responses after 10 minutes, and after
20 minutes. This difference was measured as percent inhibition (Figure 15C).
FURA-2 fluorescence ratios show no significant Ca2+ inhibition for type I cells
exposed to 1 μM SST for 10 minutes compared to controls (p=0.77). Also, Ca2+ entry
was not significantly inhibited for type I cells exposed to 1 μM SST for 20 minutes
compared to controls. After 20 minutes, control cells actually had a greater percent
inhibition than those cells exposed to 1 μM SST, but the difference between the two
groups is not statistically significant (p=0.19). After 10 and 20 minutes, control cells
had an average inhibition of 7.1% ± 3.3% , and 20.5% ± 4.1%, respectively (n=8).
Cells exposed to 1 μM SST had an average inhibition of 8.1% ± 1.7% (n=15) after 10
minutes, and 14.0% ± 2.8% (n=12) after 20 minutes.
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Figure 15
Effect of 10 and 20 minute exposures of 1 μM SST on the hypoxic response of
isolated type I cells from neonatal rat carotid bodies using Ca2+ imaging. A) Control
with 10 and 20 minute recovery in Tyrode’s solution. B) 10 and 20 minute recovery
in 1 μM SST and Tyrode’s solution. C) Histogram showing the percent inhibition of
hypoxic evoked Ca2+ influx for type I cells (p>0.05, error bars are standard error of
the mean).
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Electrophysiology
Perforated Patch Clamp
The effects of SST on the acid-induced depolarization in type I cells was
tested by exposing the cells to 1 μM SST for 2 minutes. The membrane potentials of
type I cells was recorded using the amphotericin perforated-patch configuration of
the whole-cell patch clamp technique (Burlon et al., 2009). Type I cells had an
average resting membrane potential of -42.16 mV ± 2.1 mV, (n=9). In control
experiments, acidic HEPES buffered salt solution was applied to type I cells, and the
change in membrane potential was recorded (Figure 16A). Once the depolarized
cell returned to baseline membrane potential, the cell recovered in control HEPES
buffered salt solution for 3 minutes. After the recovery period, the cell was exposed
to 1 μM SST for 2 minutes and exposed to acidic HEPES in the presence of 1 μM SST
(Figure 16B). After the cell recovered again for 5 minutes in HEPES buffered salt
solution, the acidic stimulus was applied again and the membrane depolarization
was recorded (Figure 16C).
The cells’ average depolarization was compared in the presence of acid and
no SST, acid and 1 μM SST, and acid after SST exposure (recovery) (Figure 17). The
average depolarization of a type I cell in the presence of acid was 9.7 ± 0.8 mV. The
average depolarization after a 2 minute exposure of 1 μM SST decreased to 8.2 ± 1.3
mV. However, this decrease in acid-induced depolarization in cells exposed to 1 μM
SST is not significant when compared to controls (p=0.29). The average recovery
depolarization was 8.9 ± 1.7 mV, and is not significantly different when compared to
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the depolarization in acid only (p=0.57) nor acid plus SST (p=0.72). Therefore, 1 μM
SST did not significantly inhibit the acid response of type I cells.
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Figure 16
Effect of 2 minute application of 1 μM SST on acid-induced depolarization of type I
cells using perforated patch clamp. Type I cell membrane potential in A) acid only,
B) 1 μM SST and acid, and C) acid after SST exposure.
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Figure 17
Histogram comparing average depolarization in acid only, acid plus 1 μM SST, and
acid after SST exposure. Acid caused type I cells to depolarize 9.7 ± 0.8 mV on
average, while acid with 1 μM SST caused an average depolarization of 8.2 ± 1.3 mV.
The reduction in acid-induced depolarization of 1 μM SST is not significant (n=8, p >
0.05, error bars are standard error of the mean).
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Calcium Imaging in Adult Rats
High K+ Stimulus in Adult Rat Carotid Body Type I Cells
To test whether SST acts upon the carotid body in an age-dependent manner,
Ca2+ imaging experiments were repeated with 2 minute applications of 1 μM SST in
adult rat type I cells. The effect of SST on voltage-gated Ca2+ influx in isolated type I
cells from adult rat carotid bodies was measured using Ca2+ imaging with FURA-2.
In adult rat Ca2+ imaging experiments, a high potassium stimulus was used to
evoke voltage-gated Ca2+ influx. On average, cells had an initial baseline Ca2+
340/380 ratio of 0.53 ± 0.02 (n=19). In control experiments, cells exposed to the
initial high potassium stimulus had an average fluorescence ratio increase of 0.96 ±
0.10 (n=11). Once baseline levels were reached from the initial high potassium
stimulus, cells recovered for an additional 2 minutes before being exposed to the
high potassium stimulus again (Figure 18A). Cells had an average fluorescence ratio
increase of 0.87 ± 0.09 during the high potassium stimulus at 2 minutes.
In experiments with SST, cells exposed to the initial high potassium stimulus
had an average fluorescence ratio increase of 0.79 ± 0.06 (n=8). Once baseline Ca2+
levels were reached, the cells recovered for 2 minutes in HEPES buffered salt
solution containing 1 μM SST (Figure 18B). After the 2 minute recovery, cells were
exposed to the high potassium solution in the presence of 1 μM SST. Cells exposed
to the high potassium stimulus and 1 μM SST at the 2 minute mark had an average
fluorescence ratio increase of 0.68 ± 0.06.
The first Ca2+ peak was compared to the second Ca2+ peak, and this difference
was measured as the percent inhibition (Figure 18C). FURA-2 fluorescence ratios
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show control cells had an average inhibition of 10.5 ± 1.9% inhibition (n=11). Cells
exposed to 1 μM SST had an average inhibition of 15.0 ± 1.7% inhibition (n=8).
However, the larger percent inhibition for cells exposed to 1 μM SST is not
significantly different from controls (p=0.11). Therefore, exposure of 1 μM SST for 2
minutes does not significantly inhibit voltage-gated Ca2+ influx in isolated type I cells
from adult rat carotid bodies.
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Figure 18
Effect of 2 minute exposure of 1 μM SST on isolated type I cells from the carotid
body of adult rats using Ca2+ imaging. A) Control with 2 minute recovery in HEPES
buffered salt solution. B) 2 minute recovery in 1 μM SST and HEPES buffered salt
solution. C) Histogram showing the percent inhibition of K+ evoked Ca2+ influx for
type I cells (p>0.05, error bars are standard error of the mean).
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Summary of Results
These experiments have identified the presence of SST and SSTR1-5 in
isolated type I cells from neonatal rat carotid bodies. However, when the
functionality of these receptors were tested with 1 μM SST, no effects were evident.
The data presented in this study show that SST does not significantly inhibit
voltage-gated Ca2+ influx in the type I cells of both neonatal and adult rats, nor the
acid-induced depolarization in type I cells from neonatal rats.
Previous studies have shown that when humans were infused with SST, their
ventilatory responses to hypoxia were reduced (Pedersen et al., 1999; Pandit et al.,
2014). SST was hypothesized to be working at the level of the carotid body, and e
Silva and Lewis (1995) have shown 0.1 μM SST to inhibit whole cell Ca2+ current in
rat carotid body type I cells. However, there are some important differences in the
experimental setup between the current work and the work of e Silva and Lewis
(1995). First, e Silva and Lewis (1995) did not mention how long they applied SST
on the type I cells before recording Ca2+ currents. Another key difference is that e
Silva and Lewis (1995) recorded currents at room temperature (22-26°C), while all
recordings in this report were done at 35-37°C. Finally, in e Silva and Lewis (1995),
they applied the 0.1 μM SST solution through a micropipette near the recording cell
(Figure 19A). This technique differs from the setup in present study because
temperature cannot be accounted for when using a micropipette to apply the drug.
If a colder solution is being applied to a type I cell, then the temperature, rather than
the drug, may account for a significant reduction in Ca2+ currents. In the present

82

study, the cells were perfused with a solution with a concentration of 1 μM SST at
35-37°C (Figure 19B).
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Figure 19
Schematic illustrating the different setups for Ca2+ recordings in isolated type I cells.
A) The setup of e Silva and Lewis (1995). SST was not diluted in the extracellular
solution being perfused, but rather, diluted in a separate solution in a micropipette.
The temperature of the SST solution in the micropipette could not be controlled, and
this solution was applied directly onto type I cells. The cells were perfused with an
extracellular solution and Ca2+ currents from type I cells were recorded at 22-26°C.
B) The setup of the present work. SST was diluted in the perfusing extracellular
solution, therefore the SST concentration was constant in the perfusion chamber.
The temperature for both control and experimental solutions were regulated at 3537°C.
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In response to chemostimuli, the carotid body releases neurotransmitter due
to opening of voltage-gated Ca2+ channels and Ca2+ influx. To test whether or not
SST has an inhibitory effect on voltage-gated Ca2+ entry, 2, 10, and 20 minute
exposures of 1 μM SST were applied to isolated type I cells and intracellular Ca2+
levels were recorded. A 2 minute exposure was conducted to test if SST was
working on the type I cell on a scale of minutes. Longer exposures of 10 and 20
minutes were also tested because Pandit et al. (2014) found SST to reduce the acute
hypoxic and hypercapnic ventilatory response in humans that were infused with
SST after undergoing a 15 minute period of resting breathing. In addition, Perry and
Sandle (2009) found SST to inhibit apical BK Channels in surface colonocytes in the
human colon after a 5 minute period, but maximal inhibition occurred after 25
minutes.
1 μM SST was chosen for all experiments in the present work. Initially, 0.1
μM was used in experiments, but this concentration was increased 10-fold when no
significant effects on Ca2+ influx were evident. Work presented in this thesis has
shown that SST is present in the type I cell, which suggests that the type I cell is
capable of releasing SST. Despite resting SST plasma levels occurring in the
picomolar range, the concentration of SST in the synapse between a type I cell and
afferent chemosensory fibers may be much greater than the picomolar range. It is
widely accepted that synaptically released ACh reaches millimolar concentration at
the neuromuscular junction (Scimemi & Beato 2009). This became evident when
Kuffler and Yoshikami (1975) calculated the peak concentration of ACh in the
neuromuscular synapse of the snake to be 0.3 mM. A study later calculated the frog
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and mouse neuromuscular junctions to have peak ACh cleft concentrations of 1 mM
(Matthews-Bellinger & Salpeter, 1978). Therefore, this study used a concentration
of SST much greater than what has been observed in the plasma.
When SST was shown not to have a significant inhibition on voltage-gated
Ca2+ entry, the hypoxic response of type I cells was tested. Similarly, 2, 10, and 20
minute exposures of SST had no significant effect on the hypoxic response of type I
cells.
In e Silva and Lewis (1995), they saw SST reduce Ca2+ currents in adult rats
(150-350 g). To test if SST affected voltage-gated Ca2+ entry in an age-dependent
mechanism, Ca2+ imaging experiments were repeated and SST was applied to adult
rat type I cells. However, again, there was no significant inhibition in Ca2+ when the
cells were exposed to a high potassium stimulus after a 2 minute SST exposure.
Finally, humans infused with SST also experienced a reduced ventilatory
response to hypercapnia (Pandit et al., 2014). In the present study, the effects of 1
μM SST were tested on the acid-induced depolarization of type I cells, and again, SST
had no significant inhibition.
The data reported reject the hypothesis that SST is inhibiting the acute
hypoxic and hypercapnic ventilatory response at the level of voltage-gated Ca2+
entry in type I cells. But SST may still have peripheral effects in response to
chemostimuli, despite these negative results. SST may have direct effects on vesicle
fusion machinery, inhibiting neurotransmitter release in type I cells. SST has been
shown to inhibit the fusion process between secretion vesicles and the plasma
membrane in the anterior pituitaries of rats (Draznin et al., 1986). If SST directly

87

inhibits vesicle fusion in type I cells, then neurotransmitter release will be inhibited,
and the firing rate in the CSN will be decreased, ultimately reducing the hypoxic
ventilatory response. In addition, SST may act post-synaptically on the CSN. If
SSTRs are expressed post-synaptically on the CSN, then it could be possible that SST
directly reduces the firing rate of the CSN, and thus decreases the acute ventilatory
response to hypoxia.

Future Experiments
Since SST had no effect on type I cells in all of the experiments reported, one
future experiment will be a positive control to test whether or not SSTRs are
functional. The experiment could test if SST is altering cAMP levels, using imaging
and a cAMP-sensitive dye. All SSTR subtypes are Gi-coupled and efficiently inhibit
adenylyl cyclase (Patel, 1999), so it would be predicted that SST reduces cAMP
fluorescence ratios. Jacobs et al. (2010) conducted a similar study, monitoring
intracellular cAMP levels using fluorescence resonance energy transfer (FRET).
Transgenic mice with ubiquitous expression of highly sensitive FRET-based cAMP
biosensor exchange proteins were used to measure cAMP levels in pituitary cells
(Jacobs et al., 2010). However, the FRET-based cAMP biosensor exchange protein
technique would not be useful in this project because genetically encoded protein
cannot be transfected into rat primary tissue such as the type I cell. If this technique
were to be used, all previous experiments would have to be repeated using mouse
type I cells. Many problems can arise when using type I cells isolated from the
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mouse carotid body, which include difficult dissections, very low cell yield, and
unresponsive or damaged type I cells.
Moreover, there are reports of neurotransmitters attenuating Ca2+ signaling
via muscarinic ACh receptor activation. One study has shown that histamine, acting
via autoinhibitory H3 receptors, inhibited Ca2+ signaling initiated by the activation
of muscarinic receptors in rat type I cells (Thompson et al., 2010). Similarly,
another possible future study would address whether SST interacts with excitatory
muscarinic Ca2+ signaling in isolated rat type I cells, using Ca2+ imaging. Considering
SSTR1-5 are Gi-coupled proteins, SST would be expected to oppose the stimulatory
effects of muscarinic receptors and thus attenuate Ca2+ signaling in the type I cell.
First, activation of muscarinic ACh receptors are known to inhibit TASK channels
(Czirják et al., 2001; Inoue et al., 2008). SSTRs decrease PKA via Gi-protein coupled
receptors, and a PKA-dependent pathway that inhibits TASK channels in rat carotid
body type I cells has been characterized (Xu et al., 2007). Therefore, the decrease in
PKA caused by SSTRs could activate TASK channels, opposing the effects of
muscarinic receptors (Figure 20A). Second, SSTR4 has been shown to inhibit
voltage-gated L-type Ca2+ currents via Gβγ signaling (Farrell et al., 2014), and this
could oppose voltage-gated Ca2+ influx initiated by muscarinic receptors (Thompson
et al., 2010) (Figure 20B). Third, muscarinic receptors have been shown to directly
activate Gs-proteins (Michal et al., 2007), and thus any excitatory signaling could be
opposed by simultaneous activation of inhibitory Gi-coupled SSTRs (Figure 20C).
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Figure 20
Potential pathways by which SSTR activation might inhibit muscarinic receptor
induced Ca2+ signaling. A) Muscarinic receptor (M) activation depolarizes the type I
cell by inhibiting TASK channels and opening voltage-gated Ca2+ channels. SSTR
activation inhibits PKA, which leads to an activation of TASK channels, and thus
opposes the Ca2+ influx and depolarization induced by muscarinic receptor
activation. B) SSTR activation causes Gβγ subunits to inhibit voltage-gated Ca2+
channels and Ca2+ influx. C) Muscarinic receptors may elevate cAMP levels by a Gscoupled mechanism. Activation of SSTRs would directly oppose this action with Gicoupled inhibition of adenylyl cyclase and thus reduce cAMP levels.
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Although any one of these three pathways could potentially cause SST to
inhibit Ca2+ signaling initiated from muscarinic receptor activation, the most
plausible mechanism is the Gi-protein of SSTR counteracting the Gs-protein of the
muscarinic receptor, and causing a decrease in intracellular cAMP levels. This is
because the experiments in this work have already demonstrated that SST has no
significant effect on the hypoxic response in type I cells, which involve TASKchannels. These experiments have also shown that SST has no significant effect on
voltage-gated Ca2+ influx. However, Ca2+ imaging experiments with muscarinic
receptor stimulation would only show if SSTRs are functional. To test if SSTRs are
working via a Gi-protein in the type I cell, Ca2+ imaging experiments must be
repeated with the cells incubating in the presence of the Gi-protein inhibitor,
pertussis toxin, for 3 hours. This would test if SSTRs work in a pertussis toxinsensitive Gi-protein coupled mechanism that inhibits excitatory signaling mediated
by Gs-coupled muscarinic receptors. With the Gi-protein inhibited, it can be
predicted that the inhibitory effects of SST would be attenuated in the presence of
pertussis toxin, and muscarinic receptor excitation would cause an increase in
intracellular Ca2+ levels.
Another possible experiment to pursue would be to measure
neurotransmitter release from the carotid body type I cells in the presence of SST.
Draznin et al. (1986) have shown SST to inhibit vesicle fusion in rat anterior
pituitaries. Neurotransmitter release can be measured in the type I cell using
amperometry. Neurotransmitters that are released from the cell stimulate a postsynaptic carbon fiber electrode and are recorded. Carpenter et al. (2000) used
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amperometric recordings to show that hypoxia evokes catecholamine release from
isolated type I cells in the presence of high extracellular potassium. However, this is
a difficult technique and measuring neurotransmitter release in isolated type I cells
is challenging.
One more future experiment for this project would test whether or not SST
has a post-synaptic effect on the CSN, and this can be tested using whole nerve
recordings. By measuring the membrane potential and firing rate of the CSN, it
would be anticipated that SST would reduce the firing activity in response to
hypoxia. Reduced action potential firing would be expected in the presence of SST
due to the Gi-proteins of SSTRs. But this experiment wouldn’t directly show if SST
was inhibiting at the level of the type I cell or at the level of the CSN.
Immunocytochemistry would also have to be done on the CSN to confirm the
presence of SSTRs.

Conclusion
Humans infused with SST were shown to have reduced acute ventilatory
responses to hypoxia and hypercapnia. Previous work has suggested SST to inhibit
Ca2+ currents in the carotid body, which could affect type I cell neurotransmitter
release, CSN firing, and reduced signaling to the brainstem, ultimately altering
breathing reflexes. In contrast, the results of this work show SST does not
significantly affect voltage-gated Ca2+ influx, the hypoxic response, nor the acid
response of type I cells. This data suggests that the mechanism by which SST
inhibits the acute hypoxic and hypercapnic ventilatory response is not coupled to
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voltage-gated Ca2+ influx nor the chemosensory response of type I cells. SST is likely
affecting breathing at a different level, and further work will examine the effects of
SST at the levels of the CSN and muscarinic receptors in the type I cell. These future
studies need to be completed to gain a better understanding of SST’s role in the
carotid body.
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